|
TGFBR2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62492241884138E-12 |
| Normal-vs-Stage2 |
2.56149546018491E-11 |
| Normal-vs-Stage3 |
1.11649578471429E-11 |
| Normal-vs-Stage4 |
2.40910003057593E-09 |
| Stage1-vs-Stage2 |
6.294000E-01 |
| Stage1-vs-Stage3 |
9.012200E-01 |
| Stage1-vs-Stage4 |
2.534600E-01 |
| Stage2-vs-Stage3 |
8.014800E-01 |
| Stage2-vs-Stage4 |
2.226600E-01 |
| Stage3-vs-Stage4 |
2.141600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.78650000004499E-06 |
| Caucasian-vs-AfricanAmerican |
3.290600E-01 |
| Caucasian-vs-Asian |
4.803600E-01 |
| AfricanAmerican-vs-Asian |
5.531000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
4.25879997933976E-10 |
| Male-vs-Female |
2.007800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.4179772607531E-12 |
| Normal-vs-Extreme_Weight |
1.62980740014973E-12 |
| Normal-vs-Obese |
5.2895465785241E-12 |
| Normal-vs-Extreme_Obese |
2.36022312805062E-12 |
| Normal_Weight-vs-Extreme_Weight |
9.697200E-01 |
| Normal_Weight-vs-Obese |
2.472600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.276400E-02 |
| Extreme_Weight-vs-Obese |
1.860400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.101700E-02 |
| Obese-vs-Extreme_Obese |
2.704300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.32590000487565E-08 |
| Normal-vs-Age(41-60Yrs) |
2.03990158098577E-11 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.4034000345452E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.665200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.084990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.197580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.279400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.601010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.862000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
<1E-12 |
| Normal-VS-KIRP CIMP |
2.415400E-04 |
| Normal-VS-Unclassified PRCC |
1.08440001422849E-09 |
| Type1 PRCC-VS-Type2 PRCC |
5.403400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.758000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.380200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.384200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.095970E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.877200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6251444634463E-12 |
| Normal-vs-N1 |
1.16060494548265E-11 |
| Normal-vs-N2 |
1.026170E-04 |
| N0-vs-N1 |
1.177590E-01 |
| N0-vs-N2 |
8.379200E-01 |
| N1-vs-N2 |
6.519800E-01 |
|
|
